IL113742A - Pharmaceutical mucoadhesive emulsion composition containing a cyclodextrin - Google Patents

Pharmaceutical mucoadhesive emulsion composition containing a cyclodextrin

Info

Publication number
IL113742A
IL113742A IL11374295A IL11374295A IL113742A IL 113742 A IL113742 A IL 113742A IL 11374295 A IL11374295 A IL 11374295A IL 11374295 A IL11374295 A IL 11374295A IL 113742 A IL113742 A IL 113742A
Authority
IL
Israel
Prior art keywords
cyclodextrin
composition containing
emulsion composition
pharmaceutical mucoadhesive
mucoadhesive emulsion
Prior art date
Application number
IL11374295A
Other languages
English (en)
Other versions
IL113742A0 (en
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of IL113742A0 publication Critical patent/IL113742A0/xx
Publication of IL113742A publication Critical patent/IL113742A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40Cyclodextrins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Materials For Medical Uses (AREA)
  • Adhesives Or Adhesive Processes (AREA)
IL11374295A 1994-05-18 1995-05-16 Pharmaceutical mucoadhesive emulsion composition containing a cyclodextrin IL113742A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94201402 1994-05-18

Publications (2)

Publication Number Publication Date
IL113742A0 IL113742A0 (en) 1995-08-31
IL113742A true IL113742A (en) 1999-09-22

Family

ID=8216883

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11374295A IL113742A (en) 1994-05-18 1995-05-16 Pharmaceutical mucoadhesive emulsion composition containing a cyclodextrin

Country Status (30)

Country Link
US (1) US5814330A (xx)
EP (1) EP0759741B1 (xx)
JP (1) JP3862748B2 (xx)
KR (1) KR100369703B1 (xx)
CN (1) CN1091590C (xx)
AP (1) AP731A (xx)
AT (1) ATE174790T1 (xx)
AU (1) AU680767B2 (xx)
BG (1) BG62754B1 (xx)
BR (1) BR9507873A (xx)
CZ (1) CZ285606B6 (xx)
DE (1) DE69506857T2 (xx)
DK (1) DK0759741T3 (xx)
EE (1) EE03304B1 (xx)
ES (1) ES2127529T3 (xx)
FI (1) FI964589A0 (xx)
HK (1) HK1010688A1 (xx)
HU (1) HU218082B (xx)
IL (1) IL113742A (xx)
MY (1) MY113846A (xx)
NO (1) NO309507B1 (xx)
NZ (1) NZ285761A (xx)
OA (1) OA10321A (xx)
PL (1) PL179619B1 (xx)
RO (1) RO117145B1 (xx)
RU (1) RU2164418C2 (xx)
SK (1) SK282623B6 (xx)
TW (1) TW438601B (xx)
WO (1) WO1995031178A1 (xx)
ZA (1) ZA954023B (xx)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ324157A (en) * 1995-11-28 2000-10-27 Univ Johns Hopkins Med Conditionally replicating viral vectors and their use in treating HIV
CZ289379B6 (cs) * 1996-10-24 2002-01-16 The Procter & Gamble Company Vodný prostředek absorbující pach, tvarovaný polątářkový prostředek absorbující pach a způsob výroby vodného prostředku absorbujícího pach
US6416779B1 (en) * 1997-06-11 2002-07-09 Umd, Inc. Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections
KR19990001564A (ko) * 1997-06-16 1999-01-15 유충식 용해도를 개선한 아졸계 항진균제 및 이를 함유하는 제제
DE69808670T2 (de) 1997-12-31 2003-07-03 Choongwae Pharma Corp., Seoul/Soul Herstellungsverfahren und zusammensetzung einer oralen zubereitung von itraconazol
US6683100B2 (en) 1999-01-19 2004-01-27 Novartis Ag Organic compounds
US6194181B1 (en) 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
NZ330726A (en) * 1998-06-18 2000-10-27 Dec Res Intra-vaginal delivery unit or composition containing a cyclodextrin which improves absorbtion of 17-beta oestradiol or oestradiol benzoate
GB9920167D0 (en) * 1999-08-25 1999-10-27 Avery Dennison Corp Pressure sensitive adhesive compositions
WO2001034213A1 (en) * 1999-11-09 2001-05-17 The Procter & Gamble Company Cyclodextrin compositions for odor, insect and dust mite contol
US6835717B2 (en) * 2000-03-08 2004-12-28 The Johns Hopkins University School Of Medicine β-cyclodextrin compositions, and use to prevent transmission of sexually transmitted diseases
KR100388605B1 (ko) * 2000-06-13 2003-06-25 코오롱제약주식회사 용해도 및 용해속도가 향상된 이트라코나졸의 액상 조성물 및 이를 이용한 이트라코나졸 제제와 그 제조방법
US20020013331A1 (en) * 2000-06-26 2002-01-31 Williams Robert O. Methods and compositions for treating pain of the mucous membrane
ES2314049T3 (es) 2001-02-15 2009-03-16 Access Pharmaceuticals, Inc. Formulaciones liquidas para la prevencion y el tratamiento de enfermedades y trastornos de la mucosa.
US7544348B2 (en) 2001-02-15 2009-06-09 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
DK2060259T3 (da) * 2001-11-01 2010-05-17 Spectrum Pharmaceuticals Inc Medicinske sammensætninger til intravesikal behandling af blærecancer
US8563592B2 (en) 2001-11-01 2013-10-22 Spectrum Pharmaceuticals, Inc. Bladder cancer treatment and methods
CN100384865C (zh) * 2001-11-02 2008-04-30 嵌入治疗公司 用于rna干扰的治疗用途的方法及组合物
US20050042240A1 (en) * 2002-01-28 2005-02-24 Utterberg David S. High viscosity antibacterials
US20030144362A1 (en) * 2002-01-28 2003-07-31 Utterberg David S. High viscosity antibacterials for cannulae
US6899890B2 (en) * 2002-03-20 2005-05-31 Kv Pharmaceutical Company Bioadhesive drug delivery system
US6824763B2 (en) 2002-05-30 2004-11-30 Kimberly-Clark Worldwide, Inc. Anti-fungal powder having enhanced excipient properties
US7977532B2 (en) 2002-09-05 2011-07-12 The Procter & Gamble Company Tampon with clean appearance post use
US20060140990A1 (en) * 2003-09-19 2006-06-29 Drugtech Corporation Composition for topical treatment of mixed vaginal infections
US20050095245A1 (en) * 2003-09-19 2005-05-05 Riley Thomas C. Pharmaceutical delivery system
US20060024372A1 (en) * 2004-07-29 2006-02-02 Utterberg David S High viscosity antibacterials
US9028852B2 (en) * 2004-09-07 2015-05-12 3M Innovative Properties Company Cationic antiseptic compositions and methods of use
US20060275230A1 (en) 2004-12-10 2006-12-07 Frank Kochinke Compositions and methods for treating conditions of the nail unit
BRPI0518999A2 (pt) 2004-12-10 2008-12-23 Talima Therapeutics Inc composiÇÕes e mÉtodos para tratar condiÇÕes da unidade da unha
MX2007013631A (es) * 2005-05-09 2008-01-24 Drugtech Corp Composiciones farmaceuticas de liberacion modificada.
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8679545B2 (en) * 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
US8324192B2 (en) 2005-11-12 2012-12-04 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
EP1968544A2 (en) * 2006-01-05 2008-09-17 Drugtech Corporation Drug delivery system for bioadhesion to a vulvovaginal surface
JP2009522360A (ja) * 2006-01-05 2009-06-11 ドラッグテック コーポレイション 組成物およびその使用方法
US20090123551A1 (en) * 2007-11-13 2009-05-14 Meritage Pharma, Inc. Gastrointestinal delivery systems
US20090143343A1 (en) * 2007-11-13 2009-06-04 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
JP2011503073A (ja) 2007-11-13 2011-01-27 メリテイジ ファーマ,インク. コルチコステロイド組成物
US20100216754A1 (en) * 2007-11-13 2010-08-26 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
US20090264392A1 (en) * 2008-04-21 2009-10-22 Meritage Pharma, Inc. Treating eosinophilic esophagitis
KR20130097813A (ko) 2008-04-21 2013-09-03 오토노미, 인코포레이티드 귀 질환 및 병태를 치료하기 위한 귀 조제물
US11969501B2 (en) 2008-04-21 2024-04-30 Dompé Farmaceutici S.P.A. Auris formulations for treating otic diseases and conditions
AU2009274229B2 (en) 2008-07-21 2013-08-22 Otonomy, Inc. Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders
US8784870B2 (en) * 2008-07-21 2014-07-22 Otonomy, Inc. Controlled release compositions for modulating free-radical induced damage and methods of use thereof
ES2811051T3 (es) 2008-08-20 2021-03-10 Univ California Corticosteroides para el tratamiento de enfermedades inflamatorias del tracto gastrointestinal
BR112015022025A8 (pt) 2013-03-14 2019-12-10 Hallux Inc composição e uso de um agente ativo
BR112018001900A2 (pt) 2015-07-28 2018-09-18 Otonomy, Inc. composições agonistas de trkb ou trkc e métodos para o tratamento de condições óticas
JP7033789B2 (ja) 2016-06-29 2022-03-11 オトノミー,インク. トリグリセリド耳用製剤とその使用
WO2019154895A1 (en) 2018-02-08 2019-08-15 Strekin Ag Gel formulation for preventing or treating hearing loss

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8506792D0 (en) * 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
EP0335545B2 (en) * 1988-03-29 1998-09-23 University Of Florida Pharmaceutical formulations for parenteral use
US5055303A (en) * 1989-01-31 1991-10-08 Kv Pharmaceutical Company Solid controlled release bioadherent emulsions
IT1250421B (it) * 1991-05-30 1995-04-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato con proprieta' bio-adesive.
DK0625899T3 (da) * 1992-02-12 1996-06-17 Janssen Cilag S P A Liposom-itraconazolformuleringer
US5324718A (en) * 1992-07-14 1994-06-28 Thorsteinn Loftsson Cyclodextrin/drug complexation
FR2719999B1 (fr) * 1994-05-17 1996-08-02 Georges Serge Grimberg Composition pharmaceutique à base de gomme de guar et d'un antiacide neutralisant, à laquelle peut être ajoutée une série de principes actifs thérapeutiques.

Also Published As

Publication number Publication date
FI964589A (fi) 1996-11-15
RU2164418C2 (ru) 2001-03-27
AP9600873A0 (en) 1996-10-31
KR100369703B1 (ko) 2003-04-16
BR9507873A (pt) 1997-09-23
PL317257A1 (en) 1997-04-01
RO117145B1 (ro) 2001-11-30
ATE174790T1 (de) 1999-01-15
CN1148335A (zh) 1997-04-23
NO309507B1 (no) 2001-02-12
OA10321A (en) 1997-10-07
HUT76326A (en) 1997-08-28
EP0759741A1 (en) 1997-03-05
BG62754B1 (bg) 2000-07-31
DE69506857T2 (de) 1999-08-05
AU2526495A (en) 1995-12-05
NZ285761A (en) 1997-05-26
US5814330A (en) 1998-09-29
BG100955A (en) 1998-04-30
HU9603188D0 (en) 1997-01-28
NO964853D0 (no) 1996-11-15
CZ285606B6 (cs) 1999-09-15
CZ336996A3 (en) 1997-02-12
IL113742A0 (en) 1995-08-31
ES2127529T3 (es) 1999-04-16
AP731A (en) 1999-02-08
DK0759741T3 (da) 1999-08-23
KR970702719A (ko) 1997-06-10
ZA954023B (en) 1996-11-18
WO1995031178A1 (en) 1995-11-23
TW438601B (en) 2001-06-07
CN1091590C (zh) 2002-10-02
SK282623B6 (sk) 2002-10-08
EP0759741B1 (en) 1998-12-23
NO964853L (no) 1996-11-15
EE03304B1 (et) 2000-12-15
AU680767B2 (en) 1997-08-07
DE69506857D1 (de) 1999-02-04
SK146996A3 (en) 1997-05-07
FI964589A0 (fi) 1996-11-15
JPH10500121A (ja) 1998-01-06
PL179619B1 (pl) 2000-10-31
MY113846A (en) 2002-06-29
JP3862748B2 (ja) 2006-12-27
HU218082B (hu) 2000-05-28
HK1010688A1 (en) 1999-06-25

Similar Documents

Publication Publication Date Title
IL113742A (en) Pharmaceutical mucoadhesive emulsion composition containing a cyclodextrin
HUP9802999A3 (en) Pharmaceutical composition containing n-propargyl-1-aminoindan
ZA957247B (en) Pharmaceutical compositions
HUT77377A (hu) Aeroszol készítmények
HUP9904174A3 (en) Pharmaceutical composition for transdermic delivery
HU9500229D0 (en) Pharmaceutical composition against osteoporosis
IL113329A0 (en) Benzamide-containing pharmaceutical compositions
GB9418609D0 (en) Pharmaceutical compositions
IL112639A0 (en) A pharmaceutical composition containing pravastin
ZA954469B (en) Pharmaceutical compositions
ZA959081B (en) Pharmaceutical compositions
GB9406835D0 (en) Pharmaceutical compositions
GB2295825B (en) Pharmaceutical compositions
HU9400096D0 (en) Pharmaceutical compositions
GB9400047D0 (en) Pharmaceutical compositions
GB2285923B (en) Pharmaceutical compositions containing N-acetal-cysteine
GB9425757D0 (en) A pharmaceutical composition
ZA963388B (en) A pharmaceutical composition
GB9413423D0 (en) Pharmaceutical compositions
GB9404457D0 (en) Pharmaceutical compositions
GB9406121D0 (en) Pharmaceutical compositions
ZA954838B (en) Pharmaceutical compositions
GB9407235D0 (en) Pharmaceutical compositions
GB9411933D0 (en) Pharmaceutical compositions
GB9405879D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired